Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
1 National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
2 International Centre on Birth Defects, Rome 00195, Italy
3 Institut Européen des Génomutations, 69005 Lyon, France
4 Section for Epidemiology and Medical Statistics, University of Bergen, NO-5018 Bergen, Norway
5 Office for National Statistics, London SW1V 2QQ
6 Department of Neonatalogy and Preventive Paediatrics, University of Bologna, 40138 Bologna, Italy
7 Paris Birth Defects Registry, INSERM U149, 94807 Villejuif Cedex, France
8 Northern Netherlands Registry of Birth Defects, Department of Medical Genetics, University of Groningen, 9713 AW Groningen, Netherlands
9 Portuguese Birth Defects Registry (CERAC), National Institute of Health, 1649-016 Lisbon, Portugal
10 Medical Birth Registry, Norwegian Institute of Public Health, NO-5018 Bergen
11 Dublin EUROCAT Registry of Congenital Anomalies, Department of Public Health, Eastern Regional Health Authority, Dublin 8, Republic of Ireland
12 Department of Neonatology, Rabin Medical Center, Petah Tikva 49100, Israel
13 Finnish Register of Congenital Malformations, National Research and Development Centre for Welfare and Health (STAKES), FIN-00531 Helsinki, Finland
14 Department of Genetics, AO "G Rummo," Benevento, Italy
15 Hungarian Congenital Abnormality Registry, Department of Human Genetics and Teratology, National Center for Epidemiology, H-1966 Budapest, Hungary
16 Strasbourg Birth Defects Registry, Faculty of Medicine, University of Strasbourg, 67085 Strasbourg Cedex, France
17 University of Leeds, Leeds
Objectives To evaluate the effectiveness of policies and recommendations on folic acid aimed at reducing the occurrence of neural tube defects.
Design Retrospective cohort study of births monitored by birth defect registries.
Setting 13 birth defects registries monitoring rates of neural tube defects from 1988 to 1998 in Norway, Finland, Northern Netherlands, England and Wales, Ireland, France (Paris, Strasbourg, and Central East), Hungary, Italy (Emilia Romagna and Campania), Portugal, and Israel. Cases of neural tube defects were ascertained among liveborn infants, stillbirths, and pregnancy terminations (where legal). Policies and recommendations were ascertained by interview and literature review.
Main outcome measures Incidences and trends in rates of neural tube defects before and after 1992 (the year of the first recommendations) and before and after the year of local recommendations (when applicable).
Results The issuing of recommendations on folic acid was followed by no detectable improvement in the trends of incidence of neural tube defects.
Conclusions Recommendations alone did not seem to influence trends in neural tube defects up to six years after the confirmation of the effectiveness of folic acid in clinical trials. New cases of neural tube defects preventable by folic acid continue to accumulate. A reasonable strategy would be to quickly integrate food fortification with fuller implementation of recommendations on supplements.
Read all Rapid Responses